Arrowhead Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
Luchaisi, Senior Biotech Analyst here at RBC Capital Market. And today is our great privilege to have Arrowhead as part of our 2026 Global Healthcare Conference. To represent the company, we have James Hamilton, Chief Michael Oster, as well as Vince Anzaloni, Head of IR. James and Vince, thanks so much for being here. How are you guys doing today?
Great. Thanks for inviting us. Pleasure to be here.
Great.
We have a long list of questions here, but maybe before we go into specific, maybe I'll ask to you, Vince, just big picture. I know you guys have been on the road a lot and had great engagement with investors and whatnot. What has been the feedback? What progress has the organization made over the last few months? And most importantly, what's ahead here for Arrowhead?
Is that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

